These blood thinners may have an unexpected benefit for Alzheimer’s patients
Research from Karolinska Institutet found that Alzheimer's patients with atrial fibrillation experienced slower cognitive decline when treated with newer NOAC blood thinners. In a study of 7,308 individuals, those on NOACs showed a decline of just over 0.2 MMSE points per year, suggesting potential long-term cognitive benefits. Further studies are needed to explore these effects more deeply.